Clinical Trials Browser

Astrocytoma, Brain Neoplasms, Glioblastoma, Glioma, Oligodendroglioma, Central Nervous System Neoplasms

NCT07439172 2026-02-27

PRC

Phase 2 Not yet recruiting

70 enrolled

CNS

Astrocytoma, Brain Neoplasms, Glioblastoma, Glioma, Oligodendroglioma

NCT05345002 2026-02-20

All-Trans Retinoic Acid (ATRA) Plus PD-1 Inhibition in Recurrent IDH-Mutant Glioma

Phase 2 Recruiting

55 enrolled

CNS

Astrocytoma, Glioma, Oligodendroglioma

NCT04623931 2026-01-14

Chemotherapy and Radiation Therapy for the Treatment of IDH Wildtype Gliomas or Non-histological (Molecular) Glioblastomas

Phase 2 Recruiting

40 enrolled

CNS

Astrocytoma, Glioblastoma, Oligodendroglioma

NCT05267106 2025-12-30

FIGHT-209

Phase 2 Terminated

83 enrolled 18 charts

CNS

Glioblastoma, Glioma, Oligodendroglioma, Central Nervous System Neoplasms

NCT06439420 2025-10-01

CBT-I in PBT

Phase 2 Completed

70 enrolled

CNSLymphoid

Astrocytoma, Brain Neoplasms, Glioblastoma, Glioma, Sleep Initiation and Maintenance Disorders, Lymphoma, Meningioma, Oligodendroglioma

NCT03180502 2025-07-11

Proton Beam or Intensity-Modulated Radiation Therapy in Preserving Brain Function in Patients With IDH Mutant Grade II or III Glioma

Phase 2 Active not recruiting

120 enrolled

CNS

Astrocytoma, Glioma, Oligodendroglioma

NCT03220646 2025-07-09

Abemaciclib (LY2835219) in Patients With Recurrent Primary Brain Tumors

Phase 2 Active not recruiting

64 enrolled

CNS

Astrocytoma, Brain Neoplasms, Ependymoma, Meningioma, Oligodendroglioma

NCT05297864 2025-05-23

OU-SCC-PI-4G

Phase 2 Terminated

15 enrolled 13 charts

CNS

Astrocytoma, Glioblastoma, Glioma, Oligodendroglioma

Clinical Trials

Inflammation in Primary and Secondary Malignancies of the Central Nervous System Using [C-11]-CS1P1

PRC